Bollard Group LLC Aclaris Therapeutics, Inc. Transaction History
Bollard Group LLC
- $3.81 Billion
- Q1 2025
A detailed history of Bollard Group LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bollard Group LLC holds 1,424,176 shares of ACRS stock, worth $2.25 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,424,176Holding current value
$2.25 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
113Shares Held
92.4MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$22.5 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15.2 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$14 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.97 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.85 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $105M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...